Literature DB >> 9040114

Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrine.

C L Percicot1, C R Schnell, C Debon, C Hariton.   

Abstract

The aim of this study was to set-up and validate the use of a radio-telemetry system in order to record IOP in chronic ocular hypertensive animals. The transmitter of a miniaturized radio-telemetry system was implanted in rabbits, and its catheter was tunnelled subcutaneously to the superior conjunctival sac and inserted into the midvitreous. Implantation was performed in chronic ocular hypertensive rabbits induced by an injection of alpha-chymotrypsin into the posterior chamber of the eye. The effects of 0.5% timolol maleate, 2% dorzolamide hydrochloride and 1% epinephrine were assessed and compared after topical administration in this model. Implanted radio-telemetric system into the vitreous allowed IOP measurement for more than 6 months. In this study, circadian IOP kinetic profiles were monitored in all animals over 24 h for 3 weeks. Timolol maleate was found significantly potent in reducing IOP, while changes depended on the nyctemeral period. Dorzolamide hydrochloride induced a very large IOP reduction and was found to be also well effective at night. We evidenced a biphasic time-dependent effect after topical epinephrine, with a long lasting IOP increase occurring after the administration. This change was found to be related to side effects resulting from a poor ocular tolerance of this drug in the rabbit, leading to either a complete eye closure or a higher blinking rate. By using our method, we confirmed the pressure pulses and undershoots occurring during blinking. Radio-telemetry in chronic glaucoma rabbits appears as a refined method to assess anti-glaucoma drug activity, 24 hours a day, for long-term periods in unrestrained animals, while also providing information on the ocular side effects of eye drops.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9040114     DOI: 10.1016/s1056-8719(96)00130-x

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  12 in total

1.  Correlation between biomechanical responses of posterior sclera and IOP elevations during micro intraocular volume change.

Authors:  Hugh J Morris; Junhua Tang; Benjamin Cruz Perez; Xueliang Pan; Richard T Hart; Paul A Weber; Jun Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-01       Impact factor: 4.799

2.  Increased iris-lens contact following spontaneous blinking: mathematical modeling.

Authors:  Rouzbeh Amini; Sara Jouzdani; Victor H Barocas
Journal:  J Biomech       Date:  2012-07-21       Impact factor: 2.712

3.  Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma.

Authors:  Prakash Bhagav; Vaibhav Trivedi; Darshan Shah; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

4.  Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.

Authors:  Prakash Bhagav; Hariom Upadhyay; Sajeev Chandran
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

5.  Up-regulation of semaphorin expression in retina of glaucomatous rabbits.

Authors:  Arieh S Solomon; Michal Kimron; Vered Holdengreber; Anat Nizan; Margalit Yaakobowicz; Ella Harness; Nechama I Smorodinsky; Anat Shirvan; Ari Barzilai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-21       Impact factor: 3.117

6.  Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide.

Authors:  Hemant Bhalerao; K B Koteshwara; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

7.  Ocular hypotensive effects of a Rho-associated protein kinase inhibitor in rabbits.

Authors:  Muhammad Irfan Kamaruddin; Momoko Nakamura-Shibasaki; Yu Mizuno; Yoshiaki Kiuchi
Journal:  Clin Ophthalmol       Date:  2017-03-31

8.  Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.

Authors:  Goutham R Adelli; Prakash Bhagav; Pranjal Taskar; Tushar Hingorani; Sara Pettaway; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

9.  Telemetric monitoring of 24 h intraocular pressure in conscious and freely moving C57BL/6J and CBA/CaJ mice.

Authors:  Ruixia Li; John H K Liu
Journal:  Mol Vis       Date:  2008-04-18       Impact factor: 2.367

10.  Reliable intraocular pressure measurement using automated radio-wave telemetry.

Authors:  Eleftherios I Paschalis; Fabiano Cade; Samir Melki; Louis R Pasquale; Claes H Dohlman; Joseph B Ciolino
Journal:  Clin Ophthalmol       Date:  2014-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.